Inquire about first-refusal rights to INDs for licensing at Info@therarna.com
Innate Medicines for Lifetime–Giving You Tools to Prevent Untreatable Diseases
Project #1
A potential treatment for type 1 diabetes involves using mRNA to deactivate the anti-GAD antibody. (US Patent)
Project #2
Preventing and Treating Alzheimer’s disease by creating antibodies against beta amyloid aggregates using mutated amyloid beta as antigen. (US Patent)
Project #3
Delivering therapeutic proteins via translation rather than recombinant manufacturing. (US Patent)
Project #4
mRNA-Delivered Topical Botulinum Toxin A (US Patent)
Project #5
gRNA-Driven KRAS Gene No Payload Destruction by Random Cas-9 Deletions (US Patent)
Project #6
TNF-alpha blockers as antibodies created from mutated TNF-alfa for a lifetime of treatment of rheumatoid arthritis, psoriasis, Ankylosing Spondylitis, and IBD. (US Patent)
Project #6
TNF-alpha blockers as antibodies created from mutated TNF-alfa for a lifetime of treatment of rheumatoid arthritis, psoriasis, Ankylosing Spondylitis, and IBD. (US Patent)
Project 7:
Conjugated antibodies to traverse BBB to treat neurodegenerative disorders (US Patent)
Project 8:
HIV vaccine with surface proteins and Nef protein antibodies to treat acute and latent infections (US Patent)
therarna.com 